As of 2026-03-29, the Relative Valuation of Oncternal Therapeutics Inc (ONCT) is (250.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.53 USD, the upside of Oncternal Therapeutics Inc based on Relative Valuation is -47734.6%.
The range of the Relative Valuation is (233.61) - (255.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 24.4x | 22.0x |
| Forward P/E multiples | 20.0x - 21.9x | 21.0x |
| Fair Price | (233.61) - (255.81) | (250.84) |
| Upside | -44462.9% - -48677.3% | -47734.6% |
| Date | P/E |